CATALYST PHARMACEUTICALS, INC.【CPRX】Income statement

Market cap

$2.8B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	-	-	-	-	-	-	-	500,000	102	119	141	214	398	492
Revenue growth (%)	-	-	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-	-	-	15	17	22	34	52	69
Research & development	26	28	36	10	12	11	11	20	19	16	17	20	93	13
Selling, general & administrative	-	-	-	-	-	-	-	-	37	44	50	58	134	178
Operating margin (%)	-	-	-	-	-	-	-
Operating income	-6,082,139	-5,221,140	-10,311,658	-14,591,428	-20,398,352	-19,280,201	-18,679,636	-35,295,165	32	41	52	102	87	195
Operating expenses	40	45	55	15	20	19	19	36	-	-	-	-	-	-
Income before tax	-6,391,062	-4,076,386	-12,154,596	-15,509,061	-20,232,958	-18,072,452	-18,412,377	-34,003,514	33	42	53	105	95	216
Pretax margin (%)	-	-	-	-	-	-	-	-6,800.7	32.7	35.2	37.4	48.9	23.7	44
Provision for income taxes	-	-	-	-	-	-	-	-	2	-33,092,926	13	22	23	52
Effective tax rate (%)	-	-	-	-	-	-	-	-
Net income	-6,391,062	-4,076,386	-12,154,596	-15,509,061	-20,232,958	-18,072,452	-18,412,377	-34,003,514	32	75	39	83	71	164
Net income margin (%)	-	-	-	-	-	-	-
Earnings per share	-	-	-	-	-	-	-	-	0.31	0.72	0.38	0.8	0.67	1.38
Diluted EPS	-	-	-	-	-	-	-	-	0.3	0.71	0.37	0.75	0.63	1.31
EBITDA				-	-	-	-	-	-	-	-	-	-	-